Pediatric Vaccines Market Size, Share, By Vaccines Type (Monovalent, and Multivalent), Technology (Live Attenuated Vaccines, Subunit Vaccines, Viral Vector Vaccines, Toxoid Vaccines, mRNA Vaccines, and Inactivated Vaccines), Route of Administration (Nasal, Subcutaneous Injection, Intramuscular Injection, and Oral Delivery System), Indication (Polio, Measles, Mumps, & Rubella (MMR), Influenza, Hepatitis B, Rotavirus, and Others), Distribution Channel (Hospitals, Government Organization, Healthcare Institutions, and Others) and Region - Trends, Analysis, and Forecast till 2035

• Pediatric Vaccines market is expected to increase at a rate of USD 121.3 Billion, by 2035.
• In 2024, the target market valuation was USD 46.7 Billion.
• Pediatric Vaccines market is rising at a 10.1%CAGR.

Pediatric Vaccines are specifically designed to protect children from various types of infectious diseases. This vaccines help to build immunity and prevent from serious illness that can be harmful for children. Pediatric Vaccines contains, Hepatitis B, rotavirus vaccines polio, and others, this vaccines help to prevent spread of infectious diseases. Pediatric Vaccines are an essential part of a child’s health care routine and are administered at various stages of development to ensure long-term protection from preventable diseases.

The increasing awareness about importance of vaccinations for children, and many government & global health organization funding vaccination programs in low-& middle-income countries, resulting to drive target market growth. The rising incidence of infectious diseases, growing healthcare expenditure and technological advancement for new vaccine developments, is anticipated to drive pediatric vaccines market growth.

Technological advancement in vaccine development for the development of more effective, safer, easier to administer vaccines, and adoption of combination vaccines, is expected to create significant opportunities for pediatric vaccines market growth. The increasing focus on prevention of rare diseases, and growing emphasis on preventive healthcare, is projected to fuel pediatric vaccines market size.

Impact of Generative AI in Pediatric Vaccines Market:

Artificial Intelligence (AI) significantly improving the efficiency, safety, and accessibility of vaccines. Machine learning algorithms can analyze vast amounts of data from clinical trials and help to identify formulation for vaccine production, which reduces the time required for development. AI algorithms can identify potential drug candidates by analyzing biological data and help to development of personalized vaccines. AI models can predict spread of diseases, which help to identify risk associated with pathogen, allowing for better targeting vaccination efforts. 

Key Drivers of Target Market:

Growing Government and Public Health Initiatives is Predictable to Market Growth

Governments and public health organizations play crucial role in vaccine availability, access and acceptance, through their partnerships or funding from government to provide routine vaccination schedules for children. International health organizations, such as the World Health Organization (WHO), GAVI (Global Alliance for Vaccines and Immunization), and UNICEF, run large-scale initiatives for global vaccine coverage, particularly for children in low-income and middle-income countries. The increasing investments in vaccination programs, international collaboration, and government policies to support vaccination, resulting to drive pediatric vaccines market growth.

Rising Incidence of Infectious Diseases in Children is projected to Target Market Growth

The rising incidence of infectious diseases in children is a significant driver for pediatric vaccines market growth. The growing need of effective treatment for children, which rises the demand for vaccines to prevent and control infectious diseases that can affect children health. Many infectious diseases can lead to severe complications in children, such as pneumonia, meningitis, and encephalitis, which can cause severe illness or even death in children.

The rising incidence of such diseases, increases the awareness of immunization efforts. Parents, healthcare providers, and governments acquire vaccines as an effective tool to reduce these risks and protect child’s health. As the incidence of infectious diseases increases, global health organizations, such as the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC), are heavily emphasis on rise awareness about the importance of vaccination, is projected to fuel pediatric vaccines market growth.

• For instance, according to article published by WHO, globally, infectious diseases, such as acute respiratory infections, diarrhea and malaria, with pre-term birth complications, birth asphyxia, trauma, congenital anomalies remain the leading causes of death for children under 5 age. Sub-Saharan Africa and southern Asia, projected for more than 80% of the 4.9 million under-5 deaths in 2022. Sub-Saharan Africa had the highest neonatal mortality rate in 2022 at 27 deaths per 1,000 live births, and Central & Southern Asia have 21 deaths per 1,000 live births.

Restraints:

Limited Access to Healthcare in Low-Income Regions Limits Growth of Target Market

Many low income countries faces shortage of healthcare facilities, trained healthcare professionals, and medical supplies, which makes difficult to reach essential vaccines to children. Governments may not have sufficient resources to fund widespread immunization campaigns, which making it difficult for families to get their children vaccinated on time.

• Counterbalance Statements: Organizations such as GAVI (Global Alliance for Vaccines and Immunization), UNICEF, and the World Health Organization (WHO) are focuses on improve vaccine access in low-income countries by providing financial support, technical assistance, and logistical resources. These organizations help governments for distribution of vaccines in most remote areas and provide funding for programs to ensure every children get vaccinated in undeserved regions.

Opportunities & Market Trends:

Advancement in Vaccines Technology Fuels Market Expansion

Advancements in vaccine technology contributing to the development of more effective, safer, and easier to administration of vaccines, is anticipated to drive target market. Advancement in vaccine technology includes, mRNA vaccine technology, combination vaccines, DNA vaccines, and needle-free vaccines. This technology allows for faster development and production of vaccines, making it easier to respond to emerging diseases, especially for pediatric diseases. This innovative platforms offer the ability to create vaccines for diseases that unable to traditional immunization solutions, resulting to drive growth of pediatric vaccines market share.

The pediatric vaccines market is segmented into vaccine type, technology, indication, route of administration, distribution channel and region.

Vaccines Type:

By vaccine type, pediatric vaccine are classified into monovalent, and multivalent. The Multivalent vaccines are the dominant segment in the pediatric vaccines market share. These vaccines are designed to protect against multiple diseases with a single dose, making them more convenient and cost-effective for both healthcare providers and parents. The increasing demand for combination vaccine, contributes to growth of segment in pediatric vaccines market size.

The monovalent is second dominating segment in target market, as it is target a single pathogen. These vaccines are often focused and specific, by providing immunity to a particular disease. The rise of infectious diseases, and monovalent vaccines aim to target the specific diseases help to address emerging health concerns, resulting to drive pediatric vaccines market growth in following segment.

Technology:

Based on technology, pediatric vaccines market is divided into live attenuated vaccines, subunit vaccines, viral vector vaccines, toxoid vaccines, mRNA vaccines, and inactivated vaccines. The live attenuated vaccines hold largest pediatric vaccines market share, due to often provide long-lasting immunity with fewer doses. The pathogens in these vaccines are live and replicate in the body, stimulates a strong and durable immune response, leading to pediatric vaccines market growth.

Inactivated vaccine hold the second major share in market. It is widely used for immunizing immunocompromised children which have live vaccines risk, and it is commonly used in diseases, such as polio (IPV), hepatitis a, and influenza, expected to fuel pediatric vaccines market size.

Route of Administration:

Pediatric Vaccines market by route of administration divided into nasal, subcutaneous injection, and intramuscular injection, oral delivery system. The intramuscular injection segment dominates pediatric vaccines market size, as it deliver vaccine effectively into the muscle, where it can be absorbed by the bloodstream and generate a strong immune response. This method is widely used for vaccines such as, Hepatitis B and Influenza type B vaccines, projected to fuel pediatric vaccines market growth.

Indication:

By indication, pediatric vaccines market is segmented into polio, measles, mumps, & rubella (MMR), influenza, hepatitis B, rotavirus, and others. The MMR vaccine segment dominates in pediatric vaccines market share, due to it targets three diseases, measles, mumps, and rubella aim to prevent spread diseases and provides public health. It is combination of protection against multiple diseases in single dose, leading to drive pediatric vaccines market growth.

Distribution Channel:

By distribution channel pediatric vaccines market is segmented into, hospitals, government organization, healthcare institutions, and others. The hospitals play dominating role in target pediatric vaccines market size, due to it is considered as primary source for vaccination and treatment. Hospitals are equipped with necessary infrastructure, trained medical professionals and technologies to handle advanced treatments. The high availability and supply of vaccines products in hospitals and patients’ preference for vaccine uptake in well-equipped healthcare centers, resulting to drive pediatric vaccines market growth.

Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region hold the largest pediatric vaccines market share with 38.7% share and expected to dominant region over the forecast period. North America has high immunization rate and advanced healthcare system, is projected to drive target market growth. The advancement in healthcare infrastructure, government support for immunization programs in the U.S. for pediatrics and rising demand for children’s vaccines, is anticipated to growth of pediatric vaccine share.   

• U.S. Pediatric Vaccines Market Insights:

The U.S. hold the major share in North America for target market. The U.S. has largest healthcare market, rising government support for vaccination programs, focus and increasing focus on vaccine development, research, and adoption, resulting to drive pediatric vaccines market share.

Asia Pacific: This is the fastest growing region in target market. The rapid development of pediatric vaccine, and various initiatives are investing in research & development field for innovation of advanced vaccines leading to growth of target market. The rising healthcare improvements, and rising awareness about children’s vaccination in countries such as China, Japan and India, are creating unique opportunities for the treatment, resulting to drive pediatric vaccines market growth in upcoming years.

• China Pediatric Vaccines Market Insights:

China is the dominant country in the pediatric vaccines market in Asia Pacific region. China have massive population, which rises the demand for pediatric vaccines, government support in immunization programs, increasing awareness about vaccination, and focus on diseases prevention, is responsible for growth of pediatric vaccines market size.

Europe:The pediatric vaccines market in Europe is well-established and continues to grow in forecast period. Europe is a key region for the development, distribution, and administration of pediatric vaccines, with strong market increasing by regulatory frameworks, technological advancements, and regional health initiatives. The market growth is driven by, robust healthcare systems, government-initiatives in immunization programs, and increasing demand for vaccines due to rising awareness of preventive healthcare.

• U.K. Pediatric Vaccines Market Insights:

 U.K. is a leading player in the pediatric vaccines market in Europe. The UK has one of the most robust and widely recognized pediatric immunization programs, with heavily focus on new vaccines into national vaccination schedule, is expected to growth of pediatric vaccines market size.

Pediatric Vaccines Market Report Scope:

Attribute	Details
Market Size 2025	USD 50.6 Billion
Projected Market Size 2035	USD 121.3 Billion
CAGR Growth Rate	10.1% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Billion & CAGR from 2025 to 2035
Regional scope	North America - U.S., and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India Japan, Australia Indonesia Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa – GCC, Israel South Africa, and Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Vaccines Type:

• Monovalent
• Multivalent

By Technology:

• Live Attenuated Vaccines
• Subunit Vaccines
• Viral Vector Vaccines
• Toxoid Vaccines
• mRNA Vaccines
• Inactivated Vaccines

By Route of Administration:

• Nasal
• Subcutaneous Injection
• Intramuscular Injection
• Oral Delivery System

By Indication:

• Polio
• Measles, Mumps, & Rubella
• Influenza
• Hepatitis A&B
• Rotavirus
• Others

By Distribution Channel:

• Hospitals
• Government Organization
• Healthcare Institutions
• Others

 By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the pediatric vaccines market include, Pfizer Inc., BioNTech SE, SINOVAC, and others. These key players are focusing on improving on research and development, innovative strategies, new vaccine production through strategic partnership or collaboration.  

Pediatric Vaccines Market Companies:

• Pfizer Inc.
• BioNTech SE
• SINOVAC
• Moderna, Inc.
• Merck & Co., Inc.
• GSK plc.
• AstraZeneca
• Johnson & Johnson Services, Inc.
• Indian Immunologicals Ltd.
• Zydus Group.
• Serum Institute of India Pvt. Ltd.
• Sanofi
• Zhi Fei Biological
• Dynavax Technologies
• Panacea Biotec
• FFF Enterprises, Inc.

View an Additional List of Companies in the Pediatric Vaccines Market

• In December 2024, GSK plc., announced collaboration with Zhifei Biological Products, Ltd., to commercialization of GSK’s shingles vaccines. Shingrix is a non-live, recombinant subunit vaccine indicated for the prevention of shingles in adults at aged 50 and over. It combines an antigen, glycoprotein E, with an adjuvant system, AS01e, and help to overcome the natural age-related decline in responses to immunization that protect adults ages 50 and over from shingles.
• In October 2024, The World Health Organization (WHO) recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children. WHO also issued recommendations on the advice of SAGE for new vaccines for dengue and meningitis, and IA2030 for polio. R21 is high efficient vaccine by reduces the symptomatic cases of malaria by 75% during 12 months following a 3-dose series.
• In September 2024, The Medicines and Healthcare product Regulatory Agency (MHRA) approved an adapted Moderna COVID-19 vaccines for adults and 6 months aged children. COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant, and stimulates the immune system & works the body to produce protection against COVID-19 virus.
• In August 2024, UNICF announced it has issued tender to help secure mpox vaccines with the collaboration with Africa CDC, Gavi, and the Vaccines Alliance, WHO, the Pan American Health Organization and other partners. This collaboration aimed to facilitate donations of vaccines in low income countries. This collaboration aimed to ensure vaccines are available where they are most needed, while preventing further transmission of the mpox disease.

Analyst View:

The rising awareness of vaccine-preventable diseases and increasing efforts by government and privet health organization improve vaccination program in undesirable areas. Innovations in vaccination such as mRNA vaccines, combination vaccines and long-lasting formulations, to boost immune health in single dose, and target specific pathogen from the vaccination, is projected to drive pediatric vaccines market growth.

More Related Reports

Travel Vaccines Market
Pediatric Nutrition Market
Pediatric Radiology Market
Pediatric Clinical Trials Market
Foot and Mouth Disease Vaccine Market

Company Name	Merck & Co.
Headquarter	Kenilworth, New Jersey
CEO	Robert M. Davis
Employee Count (2024)	62,908 employees